ADVANCED TECHNOLOGY FOR ASSAYING CANCER-DRUG RESISTANCE


Year of Award:
2008
Award Type:
R44
Project Number:
CA114126
RFA Number:
RFA-CA-07-039
Technology Track:
Molecular & Cellular Analysis Technologies
PI/Project Leader:
LIM, MARK
Other PI or Project Leader:
N/A
Institution:
AMBERGEN, INC
Significant advances have been made toward the development of a new generation of molecularly targeted cancer drugs, many of which are only now emerging from the pipeline. This project aims to develop a new, highly sensitive technology for detecting drug-